Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Zinc Supplementation on Appetite and Growth in Primary Malnourished Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03098810
Recruitment Status : Unknown
Verified March 2017 by Marian girgis, Ain Shams University.
Recruitment status was:  Not yet recruiting
First Posted : April 4, 2017
Last Update Posted : April 4, 2017
Sponsor:
Information provided by (Responsible Party):
Marian girgis, Ain Shams University

Brief Summary:
Zinc supplementation effect on appetite and growth of malnourished children

Condition or disease Intervention/treatment Phase
Appetite Disorders Drug: Zinc sulphate Other: Placebo Phase 4

Detailed Description:
The investigators will do s. Zinc and letting before and after zinc supplementation

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Effect of Zinc Supplementation on Appetite and Growth of Primary Malnourished Children
Estimated Study Start Date : April 1, 2017
Estimated Primary Completion Date : September 1, 2017
Estimated Study Completion Date : December 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Malnutrition

Arm Intervention/treatment
Placebo Comparator: Normal children
Placebo
Other: Placebo
Oral syrup placebo

Experimental: Malnourished children
Oral zinc sulphate syrup
Drug: Zinc sulphate
Oral syrup zinc sulphate




Primary Outcome Measures :
  1. Appetite [ Time Frame: From start of supplementation to the end of the three months of supplementation ]
    Child eating behavior questionnaire


Secondary Outcome Measures :
  1. Weight [ Time Frame: From start of supplementation to the end of the three months of supplementation ]
    Weight

  2. Height [ Time Frame: From start of supplementation to the end of the three months of supplementation ]
    Height



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   2 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • primary malnourished

Exclusion Criteria:

  • zinc supplementation in the previous 3 months Children with chronic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03098810


Contacts
Layout table for location contacts
Contact: Marian Girgis 0201223646224 mariangirgis2009@yahoo.com

Sponsors and Collaborators
Ain Shams University
Investigators
Layout table for investigator information
Principal Investigator: Marian Girgis Ain Shams University
Layout table for additonal information
Responsible Party: Marian girgis, Principal investigator, Ain Shams University
ClinicalTrials.gov Identifier: NCT03098810    
Other Study ID Numbers: 2272009
First Posted: April 4, 2017    Key Record Dates
Last Update Posted: April 4, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Feeding and Eating Disorders
Mental Disorders
Zinc Sulfate
Astringents
Physiological Effects of Drugs
Dermatologic Agents